| scholarly article | Q13442814 |
| P2093 | author name string | S. I. Rapoport | |
| J. S. Rao | |||
| H.-J. Lee | |||
| R. N. Ertley | |||
| R. P. Bazinet | |||
| J. C. DeMar | |||
| P2860 | cites work | Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals | Q24673096 |
| The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system | Q24812038 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial | Q28143204 | ||
| Sulindac inhibits activation of the NF-kappaB pathway | Q28162606 | ||
| Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression | Q28199385 | ||
| Prostaglandins and leukotrienes: advances in eicosanoid biology | Q28208246 | ||
| 5'-flanking region surrounding a human cytosolic phospholipase A2 gene | Q28243063 | ||
| Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain | Q28575972 | ||
| Chronic administration of carbamazepine down-regulates AP-2 DNA-binding activity and AP-2alpha protein expression in rat frontal cortex | Q28577710 | ||
| Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex | Q28577930 | ||
| Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks | Q28578836 | ||
| 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain | Q28582202 | ||
| Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants | Q33596978 | ||
| What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies | Q33782550 | ||
| Cross-national comparisons of seafood consumption and rates of bipolar disorders | Q33974158 | ||
| Deacylation and reacylation of neural membrane glycerophospholipids | Q34030480 | ||
| The biochemistry of n-3 polyunsaturated fatty acids | Q34465552 | ||
| Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues | Q34667719 | ||
| Cell pathology in bipolar disorder | Q34692741 | ||
| Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? | Q34714351 | ||
| Role of Ca2+-independent phospholipase A2 and n-3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation. | Q35909458 | ||
| Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2 | Q36164895 | ||
| Lipid signaling: sleep, synaptic plasticity, and neuroprotection | Q36228945 | ||
| Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors | Q36229001 | ||
| Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions | Q36305060 | ||
| An region upstream of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells | Q38334997 | ||
| Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells | Q40403810 | ||
| Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma | Q40445795 | ||
| Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. | Q40957789 | ||
| Regulation of delayed prostaglandin production in activated P388D1 macrophages by group IV cytosolic and group V secretory phospholipase A2s. | Q40958999 | ||
| Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways | Q40978833 | ||
| Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1. | Q41067650 | ||
| Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2. | Q41094611 | ||
| Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain | Q41687052 | ||
| Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. | Q42162908 | ||
| Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers | Q43594287 | ||
| Valproic acid down‐regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase‐1 and ‐2 in rat brain | Q44402831 | ||
| Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide | Q44792337 | ||
| Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain | Q45019398 | ||
| Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids | Q45166140 | ||
| n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway | Q45208057 | ||
| Cytosolic phospholipase A2alpha regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation | Q45271816 | ||
| Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. | Q46573427 | ||
| Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder | Q46718992 | ||
| One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats | Q46740273 | ||
| Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder | Q46848333 | ||
| Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment | Q48228803 | ||
| Lithium decreases turnover of arachidonate in several brain phospholipids | Q48828317 | ||
| Structural brain changes in bipolar disorder using deformation field morphometry | Q48941833 | ||
| Frontal lobe gray matter density decreases in bipolar I disorder. | Q51006334 | ||
| Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. | Q52215505 | ||
| Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine | Q72413443 | ||
| Cross-talk between secretory phospholipase A2 and cytosolic phospholipase A2 in rat renal mesangial cells | Q73872456 | ||
| Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA | Q80753306 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 151–157 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex | |
| P478 | volume | 12 |
| Q98224550 | A Novel Network Pharmacology Strategy to Decode Metabolic Biomarkers and Targets Interactions for Depression |
| Q38034841 | A multidisciplinary reconstruction of Palaeolithic nutrition that holds promise for the prevention and treatment of diseases of civilisation |
| Q37629392 | Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis |
| Q24682168 | Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications |
| Q34053662 | Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials |
| Q34382545 | Age and haplotype variations within FADS1 interact and associate with alterations in fatty acid composition in human male cortical brain tissue |
| Q34258505 | Aging decreases rate of docosahexaenoic acid synthesis-secretion from circulating unesterified α-linolenic acid by rat liver |
| Q33664124 | Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients |
| Q35844193 | Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain |
| Q37279534 | Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids |
| Q48330566 | Antidepressant-like effects of Perilla frutescens seed oil during a forced swimming test |
| Q24620380 | Arachidonic acid and the brain |
| Q55315268 | Are Polyunsaturated Fatty Acids Implicated in Histaminergic Dysregulation in Bipolar Disorder?: AN HYPOTHESIS. |
| Q34010058 | Binge ethanol-induced neurodegeneration in rat organotypic brain slice cultures: effects of PLA2 inhibitor mepacrine and docosahexaenoic acid (DHA). |
| Q22252332 | Bipolar disorder and mechanisms of action of mood stabilizers |
| Q36076753 | Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease |
| Q33653214 | Brain lipid concentrations in bipolar disorder |
| Q37301574 | Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver |
| Q42921801 | Brain phospholipid arachidonic acid half-lives are not altered following 15 weeks of N-3 polyunsaturated fatty acid adequate or deprived diet |
| Q46934944 | Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. |
| Q33507174 | Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death |
| Q48146045 | Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. |
| Q37088689 | Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex |
| Q35014292 | Chronic dietary n-6 PUFA deprivation leads to conservation of arachidonic acid and more rapid loss of DHA in rat brain phospholipids |
| Q33869517 | Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder? |
| Q48175213 | Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder |
| Q35284832 | Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain |
| Q27027307 | Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imaging |
| Q24651240 | Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder |
| Q41451042 | Dietary n-3 PUFAs Deficiency Increases Vulnerability to Inflammation-Induced Spatial Memory Impairment. |
| Q34478836 | Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain |
| Q37264230 | Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats |
| Q47361754 | Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains |
| Q36087178 | Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)β)-knockout mice |
| Q35285149 | Disturbed neurotransmitter transporter expression in Alzheimer's disease brain |
| Q33755686 | Docosahexaenoic acid supplementation during pregnancy: a potential tool to prevent membrane rupture and preterm labor |
| Q24615766 | Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study |
| Q34363951 | Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia |
| Q37334595 | Effect of dietary docosahexaenoic acid on biosynthesis of docosahexaenoic acid from alpha-linolenic acid in young rats |
| Q40436206 | Effect of repetitive daily ethanol intoxication on adult rat brain: significant changes in phospholipase A2 enzyme levels in association with increased PARP-1 indicate neuroinflammatory pathway activation |
| Q27323288 | Effects of Omega-3 Fatty Acid Supplementation on Cognitive Functions and Neural Substrates: A Voxel-Based Morphometry Study in Aged Mice. |
| Q36338174 | Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain |
| Q38605607 | Effects of dietary-induced alterations in rat brain docosahexaenoic acid accrual on phospholipid metabolism and mitochondrial bioenergetics: An in vivo(31)P MRS study |
| Q37550608 | Effects of fish oil supplementation on prefrontal metabolite concentrations in adolescents with major depressive disorder: a preliminary 1H MRS study |
| Q36502629 | Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? |
| Q36553454 | Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6. |
| Q38135915 | Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection |
| Q42879612 | Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet |
| Q33907550 | Exercise contributes to the effects of DHA dietary supplementation by acting on membrane-related synaptic systems |
| Q33993276 | Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid |
| Q35946492 | Fifteen weeks of dietary n-3 polyunsaturated fatty acid deprivation increase turnover of n-6 docosapentaenoic acid in rat-brain phospholipids |
| Q28566224 | Gene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal aging |
| Q33886495 | Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death |
| Q43045821 | Hypertension induced by omega-3 polyunsaturated fatty acid deficiency is alleviated by alpha-linolenic acid regardless of dietary source |
| Q45352953 | Hypothalamic gene expression in ω-3 PUFA-deficient male rats before, and following, development of hypertension. |
| Q34187986 | Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA2β (VIA)-deficient mice |
| Q46314435 | Inbred C57BL/6J and DBA/2J mouse strains exhibit constitutive differences in regional brain fatty acid composition |
| Q36176078 | Increased ω6-Containing Phospholipids and Primary ω6 Oxidation Products in the Brain Tissue of Rats on an ω3-Deficient Diet |
| Q37328073 | Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids |
| Q34350376 | Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease |
| Q43940892 | Maternal DHA equilibrium during pregnancy and lactation is reached at an erythrocyte DHA content of 8 g/100 g fatty acids |
| Q37414767 | Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder |
| Q38185052 | Methods for the discovery of new anti-aging products--targeted approaches |
| Q36391143 | Mitigation of Inflammation-Induced Mood Dysregulation by Long-Chain Omega-3 Fatty Acids |
| Q34762525 | Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? |
| Q24676491 | Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism |
| Q33671302 | Mood-stabilizers target the brain arachidonic acid cascade |
| Q90680208 | N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation |
| Q36340687 | Neuroinflammation and synaptic loss |
| Q34361528 | Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: Relationship with central serotonin turnover |
| Q33602402 | Omega-3 fatty acids and dementia. |
| Q35117457 | Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease |
| Q90624633 | Perinatal dietary omega-3 fatty acid deficiency reduces maternal nurturing behavior in rats: dissociation from elevated pro-inflammatory signaling |
| Q37621283 | Phospholipases A2 and inflammatory responses in the central nervous system |
| Q39077270 | Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application |
| Q38267176 | Polyunsaturated fatty acids and their metabolites in brain function and disease. |
| Q36642579 | Polyunsaturated fatty acids moderate the effect of poor sleep on depression risk |
| Q90213208 | Preventing adolescent stress-induced cognitive and microbiome changes by diet |
| Q33839172 | Quantitative contributions of diet and liver synthesis to docosahexaenoic acid homeostasis |
| Q35529104 | Regulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation |
| Q38681312 | Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings |
| Q48806626 | Role of prefrontal cortical calcium independent phospholipase A₂ in antidepressant-like effect of maprotiline |
| Q34290929 | Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice. |
| Q44886182 | Supplementation with DHA and the psychological functioning of young adults |
| Q37077987 | The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids |
| Q27319840 | The impact of chronic stress on the rat brain lipidome |
| Q38085660 | The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence |
| Q37896631 | Therapeutic use of omega-3 fatty acids in bipolar disorder. |
| Q37376003 | Three randomized controlled trials of early long-chain polyunsaturated Fatty Acid supplementation on means-end problem solving in 9-month-olds |
| Q37403850 | Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice. |
| Q33798922 | Unesterified docosahexaenoic acid is protective in neuroinflammation |
| Q30355617 | Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction |
| Q37590263 | Whole body synthesis rates of DHA from α-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats |
| Q89976756 | n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging |
| Q34081729 | n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. |
| Q39252312 | ω-3 fatty acid eicosapentaenoic acid attenuates MPP+-induced neurodegeneration in fully differentiated human SH-SY5Y and primary mesencephalic cells |
Search more.